BB Biotech AG
BION
Rank in Stocks
#4507
BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG.... BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG. This fund allocates capital to publicly traded companies worldwide, with a primary focus on firms pioneering modern biotechnology, specifically in the development of medications and diagnostic tools. The construction of its investment portfolio is guided by a fundamental analysis approach. Established on November 9, 1993, BB Biotech AG is headquartered in Switzerland.
Share Price
$61.40
Last synced: 2026-10-21
Market Cap
$3.39B
Change (1 day)
-5.95%
Change (1 year)
25.48%
Country
CH
Trade BB Biotech AG (BION)
Category
Financial Services
P/S ratio for BB Biotech AG (BION)
P/S ratio as of 2026 TTM: 0
According to BB Biotech AG latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for BB Biotech AG from 2026 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| 5.83 | - |
US
|
|
| - | - |
SE
|
|
| 7.62 | - |
US
|
|
| 3.65 | - |
US
|
|
| 12.94 | - |
US
|
